Childhood Cancer

You are here

Acute Myeloid Leukemia (AML)

Childhood acute myeloid leukemia (AML) is a cancer of the myeloid cells that form white blood cells, red blood cells or platelets. AML is the second most common form of childhood leukemia. 

Latest Acute Myeloid Leukemia (AML) grants

Wenbin Xiao, MD/PhD, Principal Investigator
Memorial Sloan-Kettering Cancer Center
RUNX1 Early Career Investigator Grants, Awarded 2020
Lucio Castilla, PhD, Principal Investigator
University of Massachusetts Medical School
Familial RUNX1 Research Grants, Awarded 2020
Charles Gawad, MD/PhD, Principal Investigator
Stanford University School of Medicine
Single-cell Pediatric Cancer Atlas Grant, Awarded 2019

Latest Acute Myeloid Leukemia (AML) blog posts

When Lilly faced surgery after relapsing, her family made the decision to donate extra tumor tissue to research instead of throwing it away. 

“We hope that Lilly’s neuroblastoma tumor can be some small part of helping other children who... more
Every day, everywhere, children are diagnosed with cancer. Right now, children are in hospitals receiving frontline treatment following a diagnosis. Other children are beginning a clinical trial following a relapse. Still others face long-... more
Last year, we shared the story of 14-year-old Eden Green, who loves to take photos and dance. Eden was in treatment for a form of childhood cancer so rare, that doctors did not have a clinical name for it. After 4 months of treatment on a... more